Parth Formulation Private Limited
About Parth Formulation Private Limited
Data last updated:
Parth Formulation Private Limited is a private limited company based in Ajmer, Rajasthan, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 25 November 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24232RJ2003PTC018777. Its GSTIN is 08AADCP6754G1Z7 (Rajasthan).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors Keshav Mundra and Laxmi Kant Mundra.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 4 H P Plaza, Ajmer, Rajasthan, India – 305001.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.52 Cr, a decline of 12% compared to the previous year. For the same year it recorded a net profit of ₹2,301 (net margin 0%) and EBITDA of ₹3.19 Lakh (EBITDA margin 2.1%). Revenue has declined at a compounded annual rate (CAGR) of 5% over three years and 4% over five years.
As per MCA filings, the company has open charges of ₹25 Lakh on record. Court records list 36 cases involving the company, including 18 filed by the company and 18 filed against it; 22 cases are pending.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
Contact details
Parth Formulation Private Limited's registered office is in Ajmer, Rajasthan. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address4 H P Plaza, Ajmer, Rajasthan, India – 305001
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
To see the full contact details of Parth Formulation Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Parth Formulation is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Parth Formulation Private Limited, buy the company report.
Financials of Parth Formulation Private Limited
FY 2025 filings availableParth Formulation Private Limited reported revenue of ₹1.52 Cr (down 12% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 4% over five years, including a 12% fall in the latest year. EBITDA fell 46% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.19 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2,301 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.1% | ||||
| Net Profit Margin | 0% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Parth Formulation Private Limited, buy the company report.
Board of directors of Parth Formulation Private Limited
Parth Formulation has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Keshav Mundra Also directs: The Chakna Bag by MB LLP, Nukad Tales LLP | Director | 20 Aug 2024 | 2 Years 2 Months | Current |
| Laxmi Kant Mundra | Director | 08 Dec 2005 | 20 Years 10 Months | Current |
Peer comparison
Parth Formulation Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Bharat Remedies Pvt Ltd | ₹1.52 Cr (FY 2024) | -23.0% | Punjab, India | |||
| Bhagwati Industrial Paints and Chemicals Private Limited | ₹1.52 Cr (FY 2024) | 51.0% | Roorkee, Uttarakhand, India | |||
| Enrick Chemicals Private Limited | ₹1.52 Cr (FY 2025) | 74.0% | Rajkot, Gujarat, India | |||
| Crimson Laboratories Pvt Ltd | ₹1.52 Cr (FY 2025) | 5.0% | Gwalior, Madhya Pradesh, India | |||
| SRP Adhesives Private Limited | ₹1.52 Cr (FY 2025) | -10.0% | Kanpur, Uttar Pradesh, India | |||
| Parth Formulation Private Limitedthis company | ₹1.52 Cr (FY 2024) | ₹2,301 | 0% | -12.0% | Ajmer, Rajasthan, India | |
| Vivid Biotech (India) Private Limited | ₹1.51 Cr (FY 2024) | -54.0% | New Delhi, Delhi, India | |||
| Cheloor Bio-Pharma & Health Care Limited | ₹1.51 Cr (FY 2025) | 0.0% | Vadapalni, Tamil Nadu, India | |||
| C-Squared Pharma India Private Limited | ₹1.51 Cr (FY 2025) | 56.0% | Mumbai, Maharashtra, India | |||
| Alcuria Pharma Private Limited | ₹1.51 Cr (FY 2025) | 21.0% | Greater Noida, Uttar Pradesh, India | |||
| Chandramouli Industries Private Limited | ₹1.51 Cr (FY 2024) | -35.0% | Dhamdha, Chhattisgarh, India |
To see the full peer comparison of Parth Formulation Private Limited, buy the company report.
Auditor
Parth Formulation Private Limited is audited by SALGIA ANKUR AND COMPANY for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SALGIA ANKUR AND COMPANY | FY 2017 | 079589 |
Shareholding
The shareholding of Parth Formulation Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Parth Formulation Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 10 Jul 2006 | 10011417 | Central Bank of India | ₹25 Lakh | Open |
To see the full charge records of Parth Formulation Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Parth Formulation Private Limited has 36 court cases on record: 18 filed by Parth Formulation, 18 filed against it. 22 cases are pending and 14 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 25 | 12 | 20 |
| District courts | 11 | 6 | 2 |
Cases on record (5 of 36)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Rajasthan | Writ petition | Filed by the company against M/S Palm Biotech Pvt Ltd | Pending |
| High Court of Rajasthan | Interim or miscellaneous application | Filed by the company against M/S Palm Biotech Pvt Ltd | Pending |
| High Court | Court case (CSTAY) | Filed against the company by M/S Parth Remedies Pvt. Ltd. | Pending |
| High Court | Appeal | Filed against the company by M/S Parth Remedies Pvt. Ltd. and 1 other | Pending |
| High Court | Interim or miscellaneous application | Filed by the company against M/S Palm Biotech Pvt Ltd | Pending |
To see the full case history of Parth Formulation Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Parth Formulation Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Parth Formulation has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AADCP6754G1Z7 | Rajasthan | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Parth Formulation Private Limited, buy the company report.
Recent activity
Parth Formulation Private Limited has 7 board changes on record since 2005: 2 appointments and 5 cessations. The latest: Keshav Mundra ceased to be Additional Director on 29 Sep 2024.
Frequently asked questions
Parth Formulation is an active private limited company based in Ajmer, Rajasthan, India. The company works in chemical products, within the chemicals industry. It was incorporated on 25 November 2003 (23+ years old) and is registered under CIN U24232RJ2003PTC018777.
Parth Formulation has 2 current directors:
- Keshav Mundra - Director
- Laxmi Kant Mundra - Director
The latest financial statements of Parth Formulation on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Parth Formulation is 08AADCP6754G1Z7, registered in Rajasthan.
The CIN (Corporate Identification Number) of Parth Formulation is U24232RJ2003PTC018777. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Parth Formulation has 36 court cases on record: 18 filed by the company and 18 filed against it. 22 are pending. Most are in the high courts.
Parth Formulation was incorporated on 25 November 2003, making it 23+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Parth Formulation by revenue are Bharat Remedies Pvt Ltd, Bhagwati Industrial Paints and Chemicals Private Limited, Enrick Chemicals Private Limited, Crimson Laboratories Pvt Ltd, SRP Adhesives Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Keshav Mundra ceased to be Additional Director on 29 Sep 2024. Mohammad Kalam ceased to be Director on 22 Aug 2024. Shyam Sunder Mundra ceased to be Director on 22 Aug 2024. Parth Formulation has 7 board changes on record in total.
The registered office of Parth Formulation is at 4 H P Plaza, Ajmer, Rajasthan, India – 305001.
Parth Formulation operates in the chemicals industry, in the chemical products segment.